Gene therapy cancer risk confirmed in small case series

A small number of cases provide strong evidence that viral vectors used in gene therapy can cause tumors, a risk long debated but previously unconfirmed. The finding validates theoretical concerns and may impact regulatory oversight and clinical trial design. The exact incidence and mechanisms remain uncertain, but the confirmation shifts the risk-benefit calculus for gene therapy programs.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works